Log in

NASDAQ:PHIOPhio Pharmaceuticals News Headlines

$2.39
+0.08 (+3.46 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.25
Now: $2.39
$2.80
50-Day Range
$1.69
MA: $2.05
$2.63
52-Week Range
$1.60
Now: $2.39
$26.78
Volume1.01 million shs
Average Volume310,942 shs
Market Capitalization$10.95 million
P/E RatioN/A
Dividend YieldN/A
Beta1.89

Headlines

Phio Pharmaceuticals (NASDAQ PHIO) News Headlines

Source:
DateHeadline
Zacks Investment Research Weighs in on Phio Pharmaceuticals Corps FY2020 Earnings (NASDAQ:PHIO)Zacks Investment Research Weighs in on Phio Pharmaceuticals Corp's FY2020 Earnings (NASDAQ:PHIO)
www.americanbankingnews.com - May 21 at 10:59 AM
Brokers Issue Forecasts for Phio Pharmaceuticals Corps Q2 2020 Earnings (NASDAQ:PHIO)Brokers Issue Forecasts for Phio Pharmaceuticals Corp's Q2 2020 Earnings (NASDAQ:PHIO)
www.americanbankingnews.com - May 20 at 8:35 AM
Short Interest in Phio Pharmaceuticals Corp (NASDAQ:PHIO) Increases By 554.3%Short Interest in Phio Pharmaceuticals Corp (NASDAQ:PHIO) Increases By 554.3%
www.americanbankingnews.com - May 18 at 5:53 PM
BRIEF-Phio Pharma Presents Data On Intasyl To Improve Cell-Based Immunotherapy At ASGCT 2020BRIEF-Phio Pharma Presents Data On Intasyl To Improve Cell-Based Immunotherapy At ASGCT 2020
www.reuters.com - May 14 at 11:58 PM
Phio Presents Data on INTASYL as an Alternative to Genetic Modification to Improve Cell-based Immunotherapy at ASGCT 2020Phio Presents Data on INTASYL as an Alternative to Genetic Modification to Improve Cell-based Immunotherapy at ASGCT 2020
finance.yahoo.com - May 14 at 6:57 PM
Phio Pharmaceuticals (NASDAQ:PHIO) Announces  Earnings ResultsPhio Pharmaceuticals (NASDAQ:PHIO) Announces Earnings Results
www.americanbankingnews.com - May 13 at 4:32 PM
BRIEF-Phio Pharmaceuticals Files For Offering Of Up To 1.84 Million Shares Of Common Stock By Selling StockholdersBRIEF-Phio Pharmaceuticals Files For Offering Of Up To 1.84 Million Shares Of Common Stock By Selling Stockholders
www.reuters.com - May 12 at 9:39 PM
BRIEF-Phio Pharmaceuticals Reports Q1 Loss Per Share $1.33BRIEF-Phio Pharmaceuticals Reports Q1 Loss Per Share $1.33
www.reuters.com - May 12 at 9:39 PM
Phio Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business UpdatePhio Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - May 12 at 9:39 PM
Short Interest in Phio Pharmaceuticals Corp (NASDAQ:PHIO) Grows By 114.0%Short Interest in Phio Pharmaceuticals Corp (NASDAQ:PHIO) Grows By 114.0%
www.americanbankingnews.com - May 11 at 9:42 PM
Phio to Present at Upcoming Medical Meetings and Investor Conference in Spring 2020Phio to Present at Upcoming Medical Meetings and Investor Conference in Spring 2020
finance.yahoo.com - May 4 at 7:46 AM
Phio Pharmaceuticals CorpPhio Pharmaceuticals Corp
www.bloomberg.com - April 26 at 5:11 PM
Phio Pharmaceuticals Corp.Phio Pharmaceuticals Corp.
www.marketwatch.com - April 25 at 8:20 PM
PHIO: Collaborations Provide Several OptionsPHIO: Collaborations Provide Several Options
finance.yahoo.com - April 7 at 3:25 PM
Phio Pharmaceuticals Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-MarketPhio Pharmaceuticals Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - April 2 at 4:05 PM
Phio Pharma down 11% on capital raisePhio Pharma down 11% on capital raise
seekingalpha.com - March 31 at 5:39 PM
Phio Pharmaceuticals Announces $4.0 Million Registered Direct Offering Priced At-the-MarketPhio Pharmaceuticals Announces $4.0 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - March 31 at 12:36 PM
Phio Announces Positive New Data Validating the INTASYL™ Immunotherapy Platform's Ability to Develop Novel Compounds Capable of Inhibiting Cancer Tumor GrowthPhio Announces Positive New Data Validating the INTASYL™ Immunotherapy Platform's Ability to Develop Novel Compounds Capable of Inhibiting Cancer Tumor Growth
finance.yahoo.com - March 31 at 7:36 AM
Phio Pharmaceuticals Corp. Common Stock (PHIO) Earnings Report DatePhio Pharmaceuticals Corp. Common Stock (PHIO) Earnings Report Date
www.nasdaq.com - March 26 at 10:40 PM
BRIEF-Phio Pharmaceuticals Reports Year End 2019 Financial Results And Provides Business UpdateBRIEF-Phio Pharmaceuticals Reports Year End 2019 Financial Results And Provides Business Update
www.reuters.com - March 26 at 10:40 PM
Phio Pharmaceuticals Reports Year End 2019 Financial Results and Provides Business UpdatePhio Pharmaceuticals Reports Year End 2019 Financial Results and Provides Business Update
finance.yahoo.com - March 26 at 5:40 PM
Phio Pharma up 30% premarket on Medigene dealPhio Pharma up 30% premarket on Medigene deal
seekingalpha.com - March 11 at 7:44 AM
BRIEF-Phio Pharmaceuticals And Helmholtz Zentrum München Announce Collaboration And Option Agreement With MedigeneBRIEF-Phio Pharmaceuticals And Helmholtz Zentrum München Announce Collaboration And Option Agreement With Medigene
www.reuters.com - March 10 at 7:14 PM
Phio Pharmaceuticals and Helmholtz Zentrum München Announce Collaboration and Option Agreement with MedigenePhio Pharmaceuticals and Helmholtz Zentrum München Announce Collaboration and Option Agreement with Medigene
finance.yahoo.com - March 10 at 7:14 PM
Phio Pharmaceuticals Announces Closing of $8.0 Million Underwritten Public OfferingPhio Pharmaceuticals Announces Closing of $8.0 Million Underwritten Public Offering
finance.yahoo.com - February 13 at 5:40 PM
BRIEF-Sabby Management Llc Reports 9.99% Passive Stake In Phio Pharmaceuticals Corp As Of Feb 11BRIEF-Sabby Management Llc Reports 9.99% Passive Stake In Phio Pharmaceuticals Corp As Of Feb 11
www.reuters.com - February 11 at 5:55 PM
Phio Pharma down 52% premarket after pricing equity offeringPhio Pharma down 52% premarket after pricing equity offering
seekingalpha.com - February 11 at 12:55 PM
BRIEF-Phio Pharmaceuticals - Pricing Of Public Offering Of 2 Million Units At Public Offering Price Of $4.00 Per UnitBRIEF-Phio Pharmaceuticals - Pricing Of Public Offering Of 2 Million Units At Public Offering Price Of $4.00 Per Unit
www.reuters.com - February 11 at 12:55 PM
Phio Pharmaceuticals Announces Compliance with Nasdaq Listing RequirementsPhio Pharmaceuticals Announces Compliance with Nasdaq Listing Requirements
finance.yahoo.com - February 10 at 9:34 AM
Phio Pharmaceuticals Announces Closing of $1.74 Million Registered Direct Offering Priced At-the-MarketPhio Pharmaceuticals Announces Closing of $1.74 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - February 6 at 1:50 PM
Phio Pharma down 13% on equity offeringPhio Pharma down 13% on equity offering
seekingalpha.com - February 5 at 1:46 PM
Phio Pharmaceuticals Announces $1.74 Million Registered Direct Offering Priced At-the-MarketPhio Pharmaceuticals Announces $1.74 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - February 5 at 1:46 PM
36 Stocks Moving In Wednesdays Mid-Day Session36 Stocks Moving In Wednesday's Mid-Day Session
www.msn.com - January 16 at 11:17 PM
Phio Pharmaceuticals (PHIO) Presents At Biotech Showcase 2020 - SlideshowPhio Pharmaceuticals (PHIO) Presents At Biotech Showcase 2020 - Slideshow
seekingalpha.com - January 14 at 3:41 PM
Phio Pharmaceuticals to Present at Biotech Showcase 2020Phio Pharmaceuticals to Present at Biotech Showcase 2020
www.prnewswire.com - January 6 at 7:52 AM
Phio Pharmaceuticals Announces Adjournment of Special Meeting of StockholdersPhio Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders
finance.yahoo.com - December 13 at 12:39 PM
Phio Pharma +51% premarket on expanding collaboration with Karolinska Institutet for RNAi immunotherapiesPhio Pharma +51% premarket on expanding collaboration with Karolinska Institutet for RNAi immunotherapies
seekingalpha.com - November 21 at 8:41 AM
Phio Pharmaceuticals and Karolinska Institutet Expand Collaboration to Develop Self-Delivering RNAi Immunotherapies for Treating Solid TumorsPhio Pharmaceuticals and Karolinska Institutet Expand Collaboration to Develop Self-Delivering RNAi Immunotherapies for Treating Solid Tumors
finance.yahoo.com - November 21 at 8:41 AM
Phio Pharmaceuticals Announces Closing of Public Offering of Common StockPhio Pharmaceuticals Announces Closing of Public Offering of Common Stock
finance.yahoo.com - November 20 at 6:46 PM
Phio Pharma down 37% premarket on pricing equity offeringPhio Pharma down 37% premarket on pricing equity offering
seekingalpha.com - November 18 at 8:54 AM
Phio Pharmaceuticals Announces Pricing of $1.0 Million Public Offering of Common StockPhio Pharmaceuticals Announces Pricing of $1.0 Million Public Offering of Common Stock
finance.yahoo.com - November 18 at 8:54 AM
PHIO: Third Quarter 2019 Financial & Operational UpdatePHIO: Third Quarter 2019 Financial & Operational Update
finance.yahoo.com - November 13 at 4:42 PM
Does Phio Pharmaceuticals Corp. (NASDAQ:PHIO) Have A Particularly Volatile Share Price?Does Phio Pharmaceuticals Corp. (NASDAQ:PHIO) Have A Particularly Volatile Share Price?
finance.yahoo.com - November 13 at 4:42 PM
Phio Pharmaceuticals Announces Proposed Public Offering of Common StockPhio Pharmaceuticals Announces Proposed Public Offering of Common Stock
finance.yahoo.com - November 13 at 4:42 PM
Phio Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business UpdatePhio Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - November 12 at 12:23 PM
Phio Pharmaceuticals to Highlight Self-delivering RNAi Technology at SITC 2019Phio Pharmaceuticals to Highlight Self-delivering RNAi Technology at SITC 2019
finance.yahoo.com - October 29 at 11:20 AM
Phio Pharmaceuticals Announces Adjournment of 2019 Annual Meeting of StockholdersPhio Pharmaceuticals Announces Adjournment of 2019 Annual Meeting of Stockholders
finance.yahoo.com - October 23 at 10:45 PM
Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its Self-Delivering RNAi Technology to Enhance Macrophage-Based Adoptive Cell TherapyPhio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its Self-Delivering RNAi Technology to Enhance Macrophage-Based Adoptive Cell Therapy
finance.yahoo.com - September 19 at 11:16 PM
Phio Pharmaceuticals (PHIO) Presents At H.C. Wainwright 21st Annual Global Investment Conference - SlideshowPhio Pharmaceuticals (PHIO) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow
seekingalpha.com - September 17 at 8:49 PM
Phio Pharma collaborates with Carisma Therapeutics to evaluate self-delivering RNAi technology; shares up 19% premarketPhio Pharma collaborates with Carisma Therapeutics to evaluate self-delivering RNAi technology; shares up 19% premarket
seekingalpha.com - September 9 at 3:57 PM
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.